ABL1/2 and DDR1 Drive MEKi Resistance in NRAS-Mutant Melanomas by Stabilizing RAF/MYC/ETS1 and Promoting RAF HomodimerizationAnastasia Lyon, Rina Plattner, Christina Meeks et al.|Cancers|2023Cited by 3